Simulations of a real-world explanatory trial of transarterial radioembolization for advanced unresectable hepatocellular carcinoma with portal vein invasion were performed to examine the effects of ...

When this is done well, biomarkers accelerate decision-making, reduce uncertainty, and ultimately bring improved therapies to patients faster. When this is done poorly, however, biomarkers can add ...

As decentralized and flexible clinical trial models mature, they have become an established component of research and ...

The integration of artificial intelligence (AI) and machine learning (ML) in oncology clinical trials is rapidly evolving alongside the broader field. For example, AI-driven adaptive trial designs may ...

New collaboration integrates Citeline's comprehensive trial databases with Evinova's AI-native Study Designer to optimize decisions to improve study outcomes Evinova, a global health tech company with ...

As sponsor needs change strategic collaboration with CDMOs/CROs is becoming more important for execution and early input.